© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to October
oral hGnRH-R hormone receptor antagonist
to treat of uterine fibroids, Ph. I completed
from cell-based 2.5M cmpd HTS + opt.
J. Med. Chem., Oct. 22, 2020 issue
Bayer AG, Berlin, DE
October’s molecule, the Bayer hGnRH-R antagonist BAY 1214784, is intended as an oral, once-daily treatment for uterine fibroids, a highly common problem in adult women that can lead to infertility. Existing…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.